Biopolitics for the 21st Century
By Marcy Darnovsky,
2020 Science
| 12. 14. 2009
Much appreciation is due to Andrew for his courage in soliciting "alternative perspectives" on technology innovation and life in the 21st century. I can't help but observe that his nervousness about doing so is one small sign that something is amiss in what he calls "the interface between emerging technologies and society."
One challenge we face in mending that interface is a tendency toward over-enthusiasm about prospective technologies. Another is the entanglement of technology innovation and commercial dynamics. Neither of these is brand new.
Back in the last century, the 1933 Chicago World's Fair took "technological innovation" as its theme and "A Century of Progress" as its formal name. Its official motto was "Science Finds, Industry Applies, Man Conforms."
The slogan shamelessly depicts "science" and "industry" as dictator - or at least drill sergeant - of humanity. It anoints industrial science as a rightful decision-maker about human ends, and an inevitable purveyor of societal uplift.
Today the 1933 World's Fair slogan seems altogether crass. But have we earned our cringe? We'd like to think that we're more realistic about science...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...